|
|
|
| Analysis of Efficacy and Safety of Rivaroxaban in the Anticoagulant Therapy of Elderly Patients with Non-valvular Atrial Fibrillation |
| ZHU Dan |
| First-author's address: Department of Pharmaceutical Affairs, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China |
|
|
